RECURRENT CUTANEOUS MELANOMA
Clinical trials for RECURRENT CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for RECURRENT CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested as last hope for Tough-to-Treat skin cancer
Disease control OngoingThis study is testing whether a pill called ibrutinib can help control advanced skin melanoma that has continued to grow despite standard immunotherapies and other targeted drugs. It involves 18 patients with stage IV melanoma who take the pill daily. The main goal is to see if t…
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:18 UTC
-
Major cancer trial tests new drug to stop deadly Melanoma's return
Disease control OngoingThis large, late-stage trial is testing if a drug called pembrolizumab works better than current standard treatments to prevent melanoma skin cancer from coming back or spreading after surgery. It enrolled over 1,300 patients with high-risk stage III or IV melanoma whose tumors w…
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Boosting the immune system to fight skin cancer before surgery
Disease control OngoingThis study is testing if a new drug combination works better than a standard drug alone to shrink melanoma tumors before surgery. It involves 60 adults with stage III melanoma that can be surgically removed. The goal is to see if the combination helps the immune system attack the…
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC